GSK's ViiV Healthcare Says US FDA Approves Tivicay PD for Pediatric HIV Patients
MT newswire2026/08/26 15:13Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
11:13 AM EDT, 08/26/2026 (MT Newswires) -- GSK's (GSK) majority-owned ViiV Healthcare unit said Wednesday the US Food and Drug Administration has approved Tivicay PD, or dolutegravir, for use with other antiretroviral medicines to treat HIV-1 infection in children weighing at least 2 kilograms, including eligible newborns. The approval covers treatment-naive or treatment-experienced patients who have not previously received an integrase strand transfer inhibitor, ViiV Healthcare said. The approval is supported by data that showed dolutegravir reached therapeutic drug levels with a safety profile consistent with that seen in older pediatric and adult patients, the company said. Price: 51.80, Change: -0.27, Percent Change: -0.52
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Australian Dollar: RBA hike risks linger – OCBC
FXStreet•2026/08/31 08:48
New Zealand Dollar: RBNZ set for second hike – BNY
FXStreet•2026/08/31 08:39
Polish Zloty: Fiscal slippage and cautious NBP weigh – Commerzbank
FXStreet•2026/08/31 08:39
Crypto prices
MoreBitcoin
BTC
$78,533.38
+0.47%
Ethereum
ETH
$2,454.05
-0.21%
Tether USDt
USDT
$0.9996
-0.03%
BNB
BNB
$688.38
-0.74%
XRP
XRP
$1.38
-0.82%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$104.04
-1.07%
TRON
TRX
$0.3349
-1.65%
Hyperliquid
HYPE
$81.87
-1.83%
Dogecoin
DOGE
$0.08304
-2.36%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now